At 12 months, the weight change for those who discontinued treatment was -2.2%, compared with a -10.9% change for persistent patients
Therefore, we performed pharmacokinetic studies of BPC157 in beagle dogs following single IV administration at a dose of 6 g/kg, single IM administration at doses of 6, 30, or 150 g/kg, and repeated IM administration at a dose of 30 g/kg for seven consecutive days
Preclinical studies describe its role in supporting tissue repair processes, including effects on muscle, tendon, ligament, and gastrointestinal tissues
Researchers studying conditions related to growth, metabolism, or recovery often include GHRP-6 in their investigations to explore its multifaceted impact